DAMPen-D II: Improving the Detection, Assessment, Management, and Prevention of Delirium in Palliative Care Units: a cluster Randomised-Controlled Trial, Economic Analysis and Process Evaluation

Professor Mark Pearson Mark.Pearson@hull.ac.uk
Reader in Implementation Science

Professor Miriam Johnson Miriam.Johnson@hull.ac.uk
Professor

Dr Chao Huang C.Huang@hull.ac.uk
Reader in Statistics

Professor Judith Cohen J.Cohen@hull.ac.uk
Director, Hull Health Trials Unit

Dr Gillian Jackson G.P.Jackson@hull.ac.uk

Ms Helen Roberts Helen.Roberts@hull.ac.uk
Patient and Public Involvement Coordinator

Professor Fliss Murtagh F.Murtagh@hull.ac.uk
Professor of Palliative Care

ImproveCare: The management of clinical uncertainty in end of life care – a feasibility cluster RCT Feb 27, 2017 - Sep 30, 2018

RDSI: A randomised controlled trial to determine the clinical and cost effectiveness of a self-management intervention for the respiratory distress symptom cluster (breathlessness-cough-fatigue) in lung cancer Jan 1, 2017 - May 31, 2019

FRAIL-HEART: Assessment of Frailty in Elderly People with Ischemic Heart Disease being considered for Revascularisation: An Observational study Apr 1, 2017 - Mar 31, 2020
To summarise the study, we will recruit patients aged 80 years or more who attend the cardiology and cardio-thoracic departments of Castle Hill Hospital, Hull and who have been given a diagnosis of coronary artery disease. The patients will be identi... Read More about FRAIL-HEART: Assessment of Frailty in Elderly People with Ischemic Heart Disease being considered for Revascularisation: An Observational study.

BREATHE: Breathlessness RElief AT HomE Apr 1, 2019 - Oct 31, 2021
A feasibility study to address this RQ:
Does a paramedic-administered short non-pharmacological complex breathlessness intervention improve breathlessness and reduce conveyance to ED for people with breathlessness crisis compared with usual practice... Read More about BREATHE: Breathlessness RElief AT HomE.

LIPS: A prospective registry-based cohort study to monitor the diagnosis and management of acute leukaemia in pregnancy Jun 1, 2018 - Feb 28, 2022
Acute leukaemia (AL) is an aggressive but potentially curable cancer that can affect women of childbearing age. When a pregnancy is complicated by a diagnosis of AL, clinicians face a complex dilemma: to balance risking the mother’s survival through... Read More about LIPS: A prospective registry-based cohort study to monitor the diagnosis and management of acute leukaemia in pregnancy.